Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
NT$ 15.55
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Meribank Biotech Co., Ltd manufactures, develops, and stores mesenchymal stem cells in Taiwan. The company engages in storage of placental umbilical cord mesenchymal stem cells, cord blood hematopoietic stem cells, and immune cells. It is also involved in cell cryopreservation protocol and postpartum nursing services. Meribank Biotech Co., Ltd was founded in 2013 and is...
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. In particular, the stock is 'expensive' on EV/EBITDA, trading
Data is available to registered users only
Buy
Sell